Posted on January 11, 2022
By Jennifer Snyder | Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy
December 21, 2021
By Kaja Natland | Organon, Regional President, Asia Pacific & Japan
As someone who enjoyed a lengthy and varied career path, the most frequent question I’ve been asked this year is why I chose to move to a new, start-up company and why at the same time, I added more change by choosing to uproot and move to the other side of the world in the […]
February 23, 2022
By Jürgen Schrapp | Bayer, Head of R&D Procurement
January 24, 2022
By Alexander M. Haydl | Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development
May 20, 2022
By Jason Rudd | Amgen, Statistical Programming Manager
November 17, 2021
By Bo Quan Tan | Lonza Singapore, Manager of Project Engineering Department
June 24, 2021
By Francis Van Parys | Cytiva, Vice President Commercial Asia Pacific
August 19, 2021
By Galym Dauletbakov | Takeda, Business Operations Head UCC
March 10, 2022
By Elizabeth Jurica | Bristol Myers Squibb, Principal Scientist
January 4, 2022
By Rebekah Martin | AstraZeneca, Senior Vice President of Reward and Inclusion
August 31, 2021
By Teresa Foy | Bristol Myers Squibb, Sr Vice President Immuno-Oncology and Cellular Therapy
March 7, 2022
By Vijetha Bhat | Lonza, Houston,Texas, Scientist, Research and Development
January 28, 2022
By Stuart Flanagan | Evotec, Group Leader
June 8, 2021
By Carolyn Carroll | SwanBio Theraputics, Chief People Officer, Winners of 2021 Life Sciences Pennsylvania Emerging Company of the Year
